Origen Therapeutics
closedOrigen Therapeutics develops therapeutic products from avian transgenic animal technology.
Launch date
Employees
Market cap
-
Enterprise valuation
€13—20m (Dealroom.co estimates Aug 2010.)
Burlingame California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$2.0m | Grant | ||
| N/A | $3.7m | Early VC | |
| Total Funding | €5.2m | ||